Cheryl Robbins Appointed Expert Panelist to AHRQ ICD-10 Workgroup

Wayne, PA and Alpharetta, GA Aug 30, 2012 — Precyse, a leader in Health Information Management (HIM) technology and services, announces that Cheryl Robbins, RHIT,CCS, Precyse director of remote coding operations, will participate as an expert panelist in the Neonatal/Pediatric workgroup on the ICD-10-CM/PCS conversion of Agency for Healthcare Research and Quality (AHRQ) Quality Indicators(QI)™. The research team at University of California Davis, under a federal contract with AHRQ, has the lead role for the conversion process.
These workgroups are being formed as part of a structured approach for converting the existing QI specifications from ICD-9-CM to ICD-10-CM/PCS, incorporating coding expertise, clinical expertise and health services research/quality measurement expertise. The workgroups will evaluate the results of automated “code mapping” from ICD-9-CM to ICD-10-CM/PCS, providing input and advice regarding similarities and differences between ICD-9-CM and ICD-10-CM/PCS codes that are mapped to each other. This workgroup process will lead to recommendations regarding how the existing AHRQ QIs should be re-specified using ICD-10-CM/PCS codes, retaining the original clinical intent of each indicator while taking advantage of the greater specificity of ICD-10-CM/PCS to improve the indicator’s validity.
“I am so honored to participate as a panelist on this ICD-10 workgroup,” said Robbins. “I am excited and ready to contribute my expertise on behalf of the Precyse team, and I am looking forward to making a difference in this thought-leading group.”
Robbins was selected due to her knowledge of health care quality measurement using administrative data in specific, relevant clinical domains, as well as her expertise in ICD-9-CM and ICD-10-CM/PCS coding; hospital quality improvement, patient safety and clinical documentation improvement; and her familiarity with the AHRQ Quality Indicators and their application.

Precyse Open Letter on ICD-10 Final Announcement

Wayne, PA and Alpharetta, GA Aug 29, 2012 — Precyse, a leader in health information management (HIM) technologies and services, leading up to the AHIMA 2012 Annual Conference and Exposition, released the following open letter from Chris Powell, president of Precyse, to all healthcare colleagues regarding the announced ICD-10 final rule. The open letter, answering a critical question at this hour: “How do we reinvigorate our planned ICD-10 implementation roadmaps?” is available below. AHIMA attendees are encouraged to visit Precyse at Booth #236 to continue the ICD-10 conversation.
Healthcare Colleagues,
On August 24, the CMS published a rule finalizing the compliance deadline for converting to the ICD-10 system of diagnostic and procedural coding to Oct. 1, 2014 from Oct. 1, 2013. HHS said the extra time would allow healthcare organizations – especially small organizations – adequate time to get prepare for the changeover.
“By delaying the compliance date of ICD-10 from October 1, 2013, to October 1, 2014, we are allowing more time for covered entities to prepare for the transition to ICD-10 and to conduct thorough testing,” HHS said in the rule. “By allowing more time to prepare, covered entities may be able to avoid costly obstacles that would otherwise emerge while in production.”
Precyse has not stopped preparing for the implementation of the new coding rules and stands ready to support and meet the needs of nearly 1,000 clients – many who rely on our management, staffing and technology solutions – through their training and implementation process. Because Precyse not only supports, but actually operates, entire HIM and coding departments for some of these clients, here are our recommendations:
1. Documentation. Increase your clinical documentation training programs for physicians and other caregivers. You should develop processes, guidance and support for improved clinical documentation under ICD-10. Improved documentation skills – even minor changes such as more specificity in their notes – create obvious financial and non-financial rewards: fewer claims denials, reduced RAC audit exposure, improved case mix index, and improved cash flows. Most important for all of us, patient care is improved when downstream clinicians can review more complete chart notes and better data is available for analytics and comparative studies. Target high volume specialties in your organization most impacted by ICD-10 and train these specialists in proper documentation while training the coding team on accurate coding; then, move to the next specialty for training.
2. Training and Development. Act now to invest in the training of your coders AND those who will use
the data. Improve the basic skills of your coders in ICD-9 areas that will also be required in ICD-10. The transition to ICD-10 has pushed healthcare to appropriately invest in training our coders as skilled knowledge workers. As part of our own ICD-10 preparations, Precyse assessed the coding skills of nearly 300 coders on our staff to evaluate their ICD-10 readiness. We found additional training needs related to anatomy, physiology and pathopharmacology, as well as opportunities to improve their understanding of coding system logic and principles. So Precyse invested in and developed a comprehensive and multifaceted training program that can be delivered via virtual webinars and our online Precyse University, while developing individual training plans for every coder. This investment has paid off for Precyse clients handsomely, yielding a better case mix index for hospitals, improved coding compliance audit results, increased coder retention, and attracting new coder recruits who are eager to develop and perfect their skills. So we recommend that you perform side-by-side ICD-9 and ICD-10 coding, assessing the documentation and coding gaps and target training based on these findings.
3. Build a strong foundation for process improvement. Assess the flow of your information across your organization and develop a plan to address gaps through process improvement and technology. Invest in automated systems that streamline the entire clinical documentation process. ICD-10 was never just about re-training medical coders–it was and is about having better data about patients and their treatments, affording vast opportunities for improvement in how data are captured and processed. This leads to a more complete and useful set of codes, which is crucial in a fully automated electronic medical record environment. Today, inefficient, labor-intensive workflows abound, whether involving clinical information inputs such as dictation and transcription; service approvals, coding, physician queries, and other myriad facets involved in billing for services; or abstracting and analyzing quality indicators to improve patient care. We also recognize the promise of future innovations such as automated speech recognition, Computer Assisted Coding using Natural Language Comprehension™ (NLC), and clinical decision support tools – but know that realizing their full promise tomorrow requires that we improve how current users interact with and use their systems today. Those of us in the health care information management/information technology community must use our skills to innovate for clinicians. We must develop workflow platforms and applications that allow health care providers to do their jobs more efficiently and effectively. We do not want to add more time and complexity to an already burdensome process.
At Precyse, our vision is a world in which meaningful information is available, whenever and wherever needed, and this information helps save time, money and lives. We are an innovation company that listens carefully to our clients and prospects; every day we challenge ourselves to come back to these clients with solutions that solve their business problems while improving patient care and outcomes. We pledge to our clients and future prospects that we will never stop innovating in the midst of very challenging times.

Precyse Appoints Three Industry Leaders to Key Positions

Wayne, PA and Alpharetta, GA Aug 2, 2012 — Precyse, a leader in health information management (HIM) technologies and services, announces the appointment of three industry leaders to influential positions targeted at supporting clients with their ICD-10 strategies and beyond. James H. Crook, Jr., a veteran of the healthcare software and services industry, has been appointed to the Precyse Advisory Council (PAC). Chris Skiffington, a proven leader in healthcare technology sales, has joined Precyse as Senior Vice President and
National Sales Manager. Debra Stenner, a market-winning healthcare IT product development and strategy expert, has joined the company as Vice President of Business Planning and Product Strategy.
Crook brings more than 30 years of experience to the Precyse Advisory Council, which functions as a source of high-level input and advice on the strategic positioning and expansion of Precyse’s service and technology offerings. The PAC also serves as a conduit for new business opportunities because of the extensive experience and networks developed by each of the council members.
“We are delighted to welcome Jim to the Precyse Advisory Council,” said Precyse CEO Jeffrey Levitt. “His deep healthcare IT experience will provide an invaluable contribution as Precyse strives to offer the HIM industry the technology necessary for the completion of strategic initiatives such as EHR, Meaningful Use, ICD-10 and other initiatives.”
As Senior Vice President and National Sales Manager, Chris Skiffington will lead the Precyse sales organization as it focuses on existing and new client sales, as well as a solution expertise. A member of the Precyse Executive Leadership Team, Skiffington will report directly to Chris Powell, president, and will be based in the company’s corporate office in Wayne.
“Chris brings tremendous expertise in healthcare, technology and sales management to his role,” said Powell. “His background in enterprise selling is well-positioned to ensure that Precyse is front and center nationally.”
In her role as Vice President of Business Planning and Product Strategy, Debra Stenner will lead Precyse’s strategic product management functions.
“Debra’s role is fundamental to our success as a true innovation company,” said Powell. “She is committed to working with our hospital and physician practice clients to find innovative ways to improve productivity, quality and accuracy, streamline processes and increase revenue.”
James H. Crook, Jr., Precyse Advisory Council Member
Crook recently retired as Chief Executive Officer of IDX Systems Corporation, a leading provider of software and services to the healthcare industry. He was responsible for all aspects of the IDX business, including overseeing relationships with customers at over 3,400 healthcare organizations and 2,400 employees working in 10 locations throughout the United States and the United Kingdom. Crook had previously served as President and Chief Operating Officer of IDX, during which time he oversaw the restructuring of the company and the implementation of a newly aligned Operating Unit model. He holds a bachelor of arts degree in Administrative Science from Colby College in Waterville, Maine.
Chris Skiffington, Senior Vice President, National Sales Manager, Precyse
Prior to joining Precyse, Skiffington led the Southeast Zone for GE Healthcare HCIT division and was responsible for the P&L’s performance across the portfolio in Alabama, Florida, Georgia, Tennessee, Louisiana, Mississippi, North Carolina and South Carolina. Prior to that, Skiffington was employed for 10 years at IBM, where he was responsible for leading and managing a 162-person, $500 million sales business and achieved award-winning sales performance year after year. He also had served as the Regional Sales Manager and Senior Sales Professional, as well as a Software Account Manager. Skiffington holds an MBA from Boston College and a bachelor of science degree in business management from Westfield State University.
Debra Stenner, Vice President of Business Planning and Product Strategy, Precyse
Stenner has more than 25 years of industry experience. She most recently was principal of Four Winds Consulting, where she aided clients in establishing go-forward product strategies and new product commercialization. She previously was vice president of business planning and product strategy, Imagecast Division, for IDX Systems Corp. She also served as a member of the Integrating the Healthcare Enterprise (IHE) initiative, a joint initiative of the Radiology Society of North America (RSNA) and the Health Information Management Systems Society (HIMSS). A graduate of the University of Wisconsin in Platteville, Stenner holds a BS in medical technology. She continues to publish healthcare technology and life sciences articles and to present at a variety of industry events.

Kerasal® Launch in Canada Progresses at Major Drug Chains and Walmart Supercenters

Cedar Knolls, NJ July 10, 2012 – Alterna LLC, makers of Kerasal®, is progressing with its launch in Canada. The Canadian launch initiated in March of this year with the listing of two Kerasal SKUs at Shoppers Drug Mart and Pharmaprix stores. In recent months, Kerasal has added distribution in most Walmart stores, Jean Coutu, Uniprix, and other chains.
Kerasal is an iconic brand in foot care, with US distribution in all major chains and Walmart. Kerasal One Step Exfoliating Moisturizing Foot Ointment is the non-prescription brand most often recommended by U.S. podiatrists for softening severely dry feet. In addition to Kerasal One Step, Kerasal ultra20 Moisturizer Daytime Therapy Foot Softening Cream is available in Canada. Kerasal ultra20 is absorbed quickly by the skin, so it is perfect for daytime use.
“Canadian consumers, like our US customers, are savvy,” says Don Carswell, Director of International Sales at Alterna. “They want a product that is fast, effective and clinically proven. Kerasal One Step exfoliates and moisturizes the skin of the feet in a single step, which saves time and increases efficacy giving consumers softer feet faster.” Mr. Carswell noted that the Kerasal One Step Foot Ointment has been awarded the seal of approval by the Canadian Podiatric Medical Association.
Alterna is supporting the launch in Canada with national television advertising with English and French versions of its new television commercial. In addition to consumer support, Kerasal samples are being distributed to over 100 Canadian podiatrists who have requested samples. Alterna LLC, the US-based maker of Kerasal, has teamed up with Associated National Brokerage, Inc., of Newmarket, Ontario to serve its customers in Canada. Alterna plans to bring additional products to the Canadian market in the near future.

HealthTech Solutions Group® Promotes Brian Montfort to Vice President of Software Development

Plano, TX Jul 20, 2012 – Brian Montfort has been promoted to vice president of software development at HealthTech Solutions Group®, a leading provider of cloud-based revenue cycle management solutions.
“Brian’s expertise has been instrumental in the development and expansion of our breakthrough, cloud-based receivables management platform, myCLAIMIQ AlphaCollector™,” said Derek Morkel, chief executive officer at HealthTech. “His knowledge and experience will continue to lead our talented team of technology professionals while supporting our company vision.”
Since joining HealthTech Solutions Group in 2010, Montfort had held the position of senior software engineer, focusing on the development of new revenue cycle software solutions. He also was responsible for providing implementation and technical guidance to hospitals accessing the company’s proprietary software.
“The incredible reception that we have had to myCLAIMIQ AlphaCollector™ and the exciting pipeline of new software developments is a direct result of the work from Brian and his team,” said Morkel. “We are extremely excited at the possibilities as we extend the functionality of our integrated, cloud-based platform to new areas of the revenue cycle.”

Alterna LLC Expands Kerasal® Brand’s Distribution

Cedar Knolls, NJ Jul 10, 2012 – Alterna LLC, makers of Kerasal® and Kerasal® Nail™, today announced that Kerasal Foot Ointment, already sold in approximately 3,200 Walmart stores, will be available in all 3,871 Walmart stores in late August. Kerasal Foot Ointment is the #1 one podiatrist recommended mass distributed non-prescription foot softener for severely dry feet, and has been sold in food, drug, and mass retail stores for over 8 years.
As a result of its successful launch this past year, Alterna’s newest product – Kerasal Nail Fungal Nail Renewal Treatment – will also expand its distribution at the world’s largest mass retailer from approximately, 1,300 stores to over 3,500 stores. Kerasal Nail is a clinically proven topical formula for rapidly improving the appearance of nails damaged by fungus or psoriasis. It is the only nail penetrating formula on the market with multiple clinical studies showing clinical signs of improvement in just two weeks. Alterna holds the exclusive license in the United States for the patented formula, developed by Moberg Derma AB.
Kerasal and Kerasal Nail are widely distributed, and also available at leading drug chains including Walgreens, CVS, and Rite Aid. Fueled by a multi-million dollar television and print advertising campaign, the Kerasal brand has experienced double digit retail sales growth over the last 52 weeks for 52 weeks ending May 13, 2012, according to data reported by IRI.

Dignity Health to Acquire U.S. HealthWorks. Health system will expand to 16 states, adding 172 medical centers

San Francisco, CA Jul 2, 2012 – Dignity Health, the fifth largest health system in the nation, announced today that it has signed a definitive agreement for the acquisition of U.S. HealthWorks, the largest independent operator of occupational medicine and urgent care centers in the United States. The deal is subject to certain regulatory approvals and is expected to be finalized in August 2012. Terms were not disclosed.
Dignity Health is extending its mission into new care settings in order to deliver quality care more efficiently and improve the overall health status of the communities it serves. The acquisition reflects organization’s vision to become a national, integrated delivery network by 2020. U.S. HealthWorks, a portfolio company of Altaris Capital Partners and Three Arch Partners, operates 172 locations nationwide, and has a network of more than 2,700 employees, including approximately 800 medical providers who deliver quality care to more than 12,000 patients each day. “We are excited to bring U.S. HealthWorks into the Dignity Health family,” said Lloyd H. Dean, president/chief executive officer of Dignity Health. “This allows us to expand our health care ministry into 16 states, and it strengthens our ability to deliver the integrated, quality care that people expect and deserve.”
Based in Valencia, Calif., U.S. HealthWorks facilities offer occupational health care and urgent care services, preventive care, pre-employment and post-offer exams and screening, and return-to-work rehabilitative care. U.S. HealthWorks partners with more than 80,000 employers, many of which are Fortune 100 companies, to help manage and reduce the cost of work-related injuries. “We are very pleased to become part of a dynamic organization like Dignity Health,” said Daniel D. Crowley, chief executive officer of U.S. HealthWorks. “Dignity Health provides a great platform for us to continue growing our network to provide high-quality health care services throughout the country.” Mr. Crowley will continue on as the president and chief executive officer of U.S. HealthWorks, which will operate through a wholly-owned, for-profit subsidiary of Dignity Health focused on the occupational health care practice.
Dignity Health plans to expand the U.S. HealthWorks operations nationally. The organization is also investing in ambulatory surgery and imaging centers through its partnerships with United Surgical Partners International (USPI) and SimonMed Imaging. Dignity Health currently has 17 joint-venture surgical centers with USPI, and 35 imaging centers with SimonMed.
Citigroup Global Markets, Inc. acted as exclusive financial advisor to Dignity Health on the transaction. Goldman Sachs acted as exclusive financial advisor to U.S. HealthWorks.

Precyse Launches White Paper and Announces KLAS Accolades at HFMA ANI 2012

Las Vegas, NV Jun 25, 2012 – Precyse, a leader in health information management (HIM) technologies and services, leading up to the HFMA Annual National Institute 2012 , released a new report titled, “Stay the Course: Trust Innovation to Guide Your ICD-10 Transition.” The new report was launched after the recent shift in the proposed compliance date for ICD-10 from Oct. 1, 2013 to Oct. 1, 2014. “Even though it is a proposed rule that has a 30-day comment period, many industry leaders do not anticipate the date to move again. So what should you do with all this extra time? Stay the course and use it as your opportunity to get prepared,” says Precyse President, Chris Powell.
The 8-page report, authored by Dee Lang, Precyse Vice President of Product Management and Strategy, advises providers to use this extra time to capture better data to create a more complete and useful set of codes, especially if you are in a more automated electronic medical record environment. “This delay provides the time you need to focus on improving your clinical documentation and determining whether it supports ICD-10. Non-specific codes are still available in ICD-10. But if we continue to use non-specific codes, what are we really accomplishing?” said Lang, “What we are going to need to do is get providers to think and act differently.”
Precyse will also announce at the show its latest accolades for its precyseCode™ computer assisted coding (CAC) solution. In a KLAS report titled “Computer-Assisted Coding: A Glimpse at the Future of HIM Technology,” Precyse was “praised for [its] strong technology and received the highest scores of providers’ perception that their solution will meet their needs,” wrote Graham Triggs, author of the KLAS report.
While ICD-10 readiness, increased productivity and improved efficiency are major forces behind the interest in CAC, Precyse believes providers should also focus on the clinical and quality implications of CAC.
And Precyse isn’t the only one receiving accolades. Precyse client, Baptist Health System (BHS) was awarded the 2012 MAP Award for High Performance in Revenue Cycle by HFMA. The award was given for an achievement of measurable excellence in the revenue cycle and
their model will be used as a best practice for the healthcare industry. Precyse is a sponsor of HFMA ANI 2012 and will be located at Booth #1653 – where it will be conducting demonstrations of precyseCode and the latest enhancements to Precyse University™ education program, which offers one-of-a-kind education and training delivered onsite or online to enhance the knowledge and expertise for all populations impacted by ICD-10.
More than 1,000 hospitals are now committed to Precyse University education. Equipped with more than 300 coders and hundreds of HIM and clinical professionals on staff, Precyse has a track record of developing tried and true educational content to keep its team of experts consistently meeting or exceeding industry accuracy and timeliness benchmarking standards. Precyse has used this same approach for building its ICD-9 and ICD-10 education content. The Precyse ICD-10 education content is available online through Precyse University or the HealthStream Learning Center®.

Sparta Systems to Discuss Compliance and Quality Assurance at 2012 DIA Annual Meeting

Holmdel, NJ Jun 24, 2012 – Sparta Systems, Inc., the market leader in enterprise quality and compliance management solutions, today announced that KR Karu, the Company’s pharmaceutical industry principal, has been chosen to speak at the DIA Annual Meeting in Philadelphia, Pa., June 24-28, 2012. KR’s presentation will discuss automating Good Clinical Practice (GCP)/Good Laboratory Practice (GLP) audit reporting processes in a quality management solution.
KR will provide a step-by-step roadmap for automation of critical preclinical and clinical auditing processes within a quality management system. Those who attend will have a clear understanding of how they can reduce the time and resources typically associated with managing GLP and GCP audit processes, a more effective solution to collecting data necessary for reporting to authorities.
The DIA Annual Meeting provides professionals across all disciplines the latest in advancing the discovery, development and life cycle management of safe and effective medical products.

Sanquin Selects TrackWise® Solution to Manage Blood Bank Risks

Holmdel, NJ Jun 13, 2012 – Sparta Systems, Inc., the market leader in enterprise quality and compliance management solutions, today announced that Sanquin, the Blood Supply Foundation in the Netherlands, has selected Sparta’s TrackWise Enterprise Quality Management Software (EQMS) to handle change control, deviations, complaints, risk management and audit processes. “Donor and patient safety comes first in our line of work, so the ability to track changes, deviations, complaints, corrective measures and possible risks are extremely important,” said Peter van Mourik, Director Quality & Regulatory Affairs at Sanquin. “TrackWise consolidated multiple disparate systems, helping streamline our quality processes while saving us time and money.”
The first phase of Sanquin’s implementation focused on its plasma products division and went live in December 2011. The use of TrackWise in Sanquin’s blood banks and other divisions is phase two of the project, and it is scheduled to be fully implemented at the end of December 2012. In both phases, Sanquin is utilizing TrackWise for complaints, change control, deviations, Out of Specifications (OOS), Corrective and Preventive Actions (CAPA), risk management and audits.
“TrackWise launched without a hitch and we’re thrilled that the system generated user feedback that has been extremely valuable to Sanquin from day one,” said Nathan Birtle, VP Sales at Sparta Systems Europe. “Sanquin must help ensure a safe and efficient blood supply in the Netherlands, making accurate reporting crucial to its business. TrackWise monitors the relevant quality parameters and can quickly detect issues, so Sanquin can maintain their high level of quality and safety standards more easily.”